Stereotactic body radiotherapy for centrally-located lung tumors with 56 Gy in seven fractions: A retrospective study

Stereotactic body radiotherapy (SBRT) for centrally-located lung tumors remains a challenge because of the increased risk of treatment-related adverse events (AEs), and uncertainty around prescribing the optimal dose. The present study reported the results of central tumor SBRT with 56 Gy in 7 fract...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Shuri, Yamashita, Hideomi, Haga, Akihiro, Ota, Takeshi, Takahashi, Wataru, Ozaki, Sho, Nawa, Kanabu, Imae, Toshikazu, Abe, Osamu, Nakagawa, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126178/
https://www.ncbi.nlm.nih.gov/pubmed/30214585
http://dx.doi.org/10.3892/ol.2018.9188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126178/
https://www.ncbi.nlm.nih.gov/pubmed/30214585
http://dx.doi.org/10.3892/ol.2018.9188

Ejemplares similares